Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arotinolol combined with different calcium channel blockers for essential hypertension
ChiCTR-TRC-14004132Phase 4Completed
- Sponsor
- Tongji Hospital
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of arotinolol, amlodipine, felodipine and nifedipine in essential hypertension (3 arms), sponsored by Tongji Hospital. Primary endpoint: Blood pressure. Started Dec 2014; status: completed.
02
Drugs
arotinololamlodipinefelodipinenifedipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on ChiCTR-TRC-14004132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004132.